- Impact Factor: 3.617
- Indexed In: Web of Science, PubMed/MEDLINE, PubMed Central, SCOPUS, and DOAJ
- Publication is subject to payment of an article processing charge (APC)
- Submit here
ASN NEURO (ASN) is an open access, peer-reviewed journal which focuses on the most recent advances across the breadth of the cellular and molecular neurosciences. Please see the Aims and Scope tab for further information.
Submit your manuscript at http://mc.manuscriptcentral.com/asnneuro.
Please see the Submission Guidelines tab for more information on how to submit your article to the journal.
Open access article processing charge (APC) information
Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons license.
The APC for this journal varies depending on the article type and membership.
Original Papers, Reviews, Methods and Commentaries
The article processing charge (APC) is payable only if your article is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Tax-exempt status can be indicated by providing appropriate registration numbers when payment is requested. Please see further details here.
Please direct any queries to email@example.com.
There is no charge for submitting a paper to ASN NEURO. Upon acceptance of your manuscript, you will be charged a one-time Article Processing Charge (APC). This fee covers the cost of publication and ensures that your article will be freely available.
|Douglas L. Feinstein||University of Illinois, Chicago, USA|
|Monica Carson||University of California, Riverside, USA|
|Sandra J. Hewett||Syracuse University, USA|
|Scott T. Brady||University of Illinois, Chicago, USA|
|Carol A. Colton||Duke University, USA|
|Christopher S. Colwell||University of California, Los Angeles, USA|
|Iryna M. Ethell||University of California, Riverside, USA|
|Wendy Macklin||University of Colorado, Denver, USA|
|Mary C. McKenna||University of Maryland, USA|
|Arturo Ortega||Centro de Investigación y de Estudios Avanzados del IPN, Ciudad de México, Mexico|
|Vladimir Parpura||The University of Alabama at Birmingham, USA|
|Juana M. Pasquini||Universidad De Buenos Aires, Argentina|
|Thomas Seyfried||Boston College, USA|
|Anthony T. Campagnoni||University of California, Los Angeles, USA|
|Pedro Bekinschtein||Universidad De Buenos Aires, Argentina|
|Glyn Dawson||The University of Chicago, USA|
|Ted M. Dawson||John Hopkins University, USA|
|Fernanda de Felice||Universidade Federal do Rio de Janeiro, Brazil|
|Cheryl F. Dreyfus||Rutgers University, USA|
|Jeffrey L. Dupree||Virginia Commonwealth University, USA|
|Todd Fiacco||University of California, Riverside, USA|
|Wilma J. Friedman||Rutgers University, Newark, USA|
|Babette Fuss||Virginia Commonwealth University, USA|
|Elena Galea||Institute of Neurosciences at Barcelona, Spain|
|Yong-Jing Gao||Institute of Pain Medicine, Nantong University, Nantong, China|
|David Gavin||University of Illinois, Chicago, USA|
|Zhefeng Gong||Zhejiang University School of Medicine, China|
|Alex Gow||Wayne State University, USA|
|Judith B. Grinspan||University of Pennsylvania, USA|
|Mario Guido||Universidad Nacional de Cordoba, Argentina|
|Gaylia Harry||NIH, USA|
|Michael T. Heneka||University Bonn, Germany|
|Margaret Ho||Shanghai Tech, China|
|Rajesh Khanna||University of Arizona, USA|
|Tammy Kielian||University of Nebraska, USA|
|Steven W. Levison||Rutgers University, USA|
|David Loane||University of Maryland, USA|
|Laura Morelli||Fundacion Instituto Leloir, Argentina|
|Chris Naus||University of British Columbia, Canada|
|Andre Obenaus||University of California, USA|
|Donna Osterhout||Upstate Medical University, Syracuse, USA|
|Subhash Pandey||University of Illinois, Chicago, USA|
|Elior Peles||The Weizmann Institute of Science, Israel|
|Gustavo Pigino||University of Illinois, Chicago, USA|
|David Pleasure||University of California, Davis, USA|
|Samuel J. Pleasure||University of California, San Francisco, USA|
|Matthew M. Rasband||Baylor College of Medicine, USA|
|Fabiola Mara Ribeiro||Universidade Federal de Minas Gerais, Brazil|
|Eliana Scemes||Albert Einstein College of Medicine, USA|
|Pankaj Seth||National Brain Research Center, Manesar, India|
|Ying Shen||Zhejiang University School of Medicine, China|
|Robert P. Skoff||Wayne State University, USA|
|Ueli Suter||University of Zurich, Switzerland|
|Yu-Feng Wang||Harbin Medical University, Harbin, China|
|Scott R. Whittemore||University of Louisville, USA|
|Teresa Wood||Rutgers University, USA|
|Seema Tiwari Woodruff||University of California, USA|
|Lawrence Wrabetz||University of Buffalo, USA|
|Jiawei Zhou||Chinese Academy of Sciences, Shanghai, China|
This Journal is a member of the Committee on Publication Ethics.
This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Please read the guidelines below then visit the journal’s submission site http://mc.manuscriptcentral.com/asnneuro to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.
Only manuscripts of sufficient quality that meet the aims and scope of ASN Neuro will be reviewed.
As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.
Please Read the Manuscript Submission Guidelines below before submitting your manuscript here:
- Open Access
- Article processing charge (APC)
- What do we publish?
3.1 Aims & scope
3.2 Article types
3.3 Writing your paper
3.3.1 Making your article discoverable
- Editorial policies
4.1 Peer Review Policy
4.3.1 Writing assistance
4.5 Declaration of conflicting interests
4.6 Research ethics and patient consent
4.7 Clinical Trials
4.8 Reporting guidelines
- Publishing policies
5.1 Publication ethics
5.1.2 Prior publication
5.2 Contributor's publishing agreement
- Preparing your manuscript
6.1 Word processing formats
6.2 Artwork, figures and other graphics
6.3 Supplementary material
6.4 Reference style
6.5 English language editing services
6.6 Formatting your manuscript
6.7 Resource Identification Initiative and Research Resource Identifiers (RRIDs)
- Submitting your manuscript
7.1 How to submit your manuscript
7.2 Title, keywords and abstracts
7.3 Information required for completing your submission
7.6 Submission checklist
- On acceptance and publication
8.1 SAGE Production
8.2 Continuous publication
8.3 Promoting your article
- Further information
ASN Neuro is an open access, peer-reviewed journal. Each article accepted by peer review is made freely available online immediately upon publication, is published under a Creative Commons license and will be hosted online in perpetuity. Publication costs of the journal are covered by the collection of article processing charges which are paid by the funder, institution or author of each manuscript upon acceptance. There is no charge for submitting a paper to the journal.
If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable. This APC covers the cost of publication and ensures that your article will be freely available online in perpetuity under a Creative Commons license.
For Original Papers, Reviews, Methods, and Commentaries:
The article processing charge (APC) for American Society for Neurochemistry members is $999.The cost for non-members is $1950.
For Short Contributions:
The APC for Short Contributions by ASN members is $499. The non-member Short Contribution APC is $999.
Before submitting your manuscript to ASN Neuro, please ensure you have read the Aims &
- Original Papers
- Review Papers
- Short Contributions
- Meeting Reports (up to 3 pages, no more than 1 table or figure)
- Commentaries and Viewpoints
- Commentaries and/or views may be short and focused opinion articles, commentaries on papers recently published in ASN Neuro or elsewhere, or commentaries on significant conceptual changes, important trends or new directions in the field. They may discuss the findings, implications, and/or outcomes of specific research or wider research on a general topic, and elaborate on or offer original ideas about a specific paper or a widely-researched subject. Commentaries differ from reviews in that they present the author’s original ideas and suggestions instead of only collating and reporting the previous research. They may include figures and up to 30 references. Please include an abstract of 150-200 words and 5-10 key words for indexing purposes. Please note: Commentaries over 4 pages long will be charged the full APC ($1950 non-member/$999 member).
- Mini Reviews and Case Reports (up to 4 pages, including no more than 2 tables or figures)
- Case reports:
In general case reports and case studies will not be accepted, unless there is a clear demonstration, indication and/or discussion of neurochemical or neuroscience relevant mechanisms or implications. If you wish to submit a case report or study, it is suggested you first submit a brief letter to the EIC who will decide.
The SAGE Author Gateway has some general advice and on how to get published, plus links to further resources.
When writing up your paper, think about how you can make it discoverable. The title, keywords and abstract are key to ensuring readers find your article through search engines such as Google. For information and guidance on how best to title your article, write your abstract and select your keywords, have a look at this page on the Gateway: How to Help Readers Find Your Article Online.
ASN Neuro is a member of the Neuroscience Peer Review Consortium (http://nprc.incf.org). The Consortium is an alliance of neuroscience journals that have agreed to accept manuscript reviews from each other. Its goals are to support efficient and thorough peer review of original research in neuroscience, speed the publication of research reports and reduce the burden on peer reviewers. Therefore if a paper is deemed inappropriate for one of the Consortium member journals, authors can submit their manuscript, together with the reviews, to one of the other member journals including ASN Neuro, for consideration.
The journal’s policy is to have manuscripts reviewed by two expert reviewers. ASN Neuro utilizes a double-blind peer review process in which the reviewer’s and author’s name and information are withheld from eachother. Authors must remove all identifying information from their manuscript before they submit it. Identifying information can go in the Cover Letter. All manuscripts are reviewed as rapidly as possible, while maintaining rigor. Reviewers make comments to the author and recommendations to the Editor-in-Chief/Senior Editor who then makes the final decision.
The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor / Board member will have no involvement in the decision-making process.
ASN Neuro is committed to delivering high quality, fast peer-review for your paper, and as such has partnered with Publons. Publons is a third party service that seeks to track, verify and give credit for peer review. Reviewers for ASN Neuro can opt in to Publons in order to claim their reviews or have them automatically verified and added to their reviewer profile. Reviewers claiming credit for their review will be associated with the relevant journal, but the article name, reviewer’s decision and the content of their review is not published on the site. For more information visit the Publons website.
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
(i) Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
(ii) Drafted the article or revised it critically for important intellectual content,
(iii) Approved the version to be published,
(iv) Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Authors should meet the conditions of all of the points above. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on
All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.
Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance. It is not necessary to disclose use of language polishing services.
Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.
ASN Neuro requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
It is the policy of ASN Neuro to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’.
For guidance on conflict of interest statements, please see the ICMJE recommendations.
Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki.
Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.
For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal. Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative.
Please also refer to the ICMJE Recommendations for the Protection of Research Participants
All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals. published by the International Association of Veterinary Editors.
ASN Neuro conforms to the ICMJE requirement that clinical trials are registered in a WHO approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and metaanalyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.
Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.
SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway.
ASN Neuro and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.
If material has been previously published, it is not generally acceptable for publication in a SAGE journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in doubt, contact the Editor at the address given below.
Before publication SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. ASN Neuro publishes manuscripts under Creative Commons licenses. The standard license for the journal is Creative Commons by Attribution (CC BY), which allows others to re-use the work without permission as long as the work is properly referenced. For more information, you are advised to visit SAGE's OA licenses page.
Alternative license arrangements are available, for example, to meet particular funder mandates, made at the author’s request.
The preferred format for your manuscript is Word. Word templates are available on the Manuscript Submission Guidelines page of our Author Gateway.
Your manuscript file should be submitted as a single DOC file containing all text, tables, figures and schema. Supplementary material should be submitted as a separate file.
For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines.
Figures supplied in color will appear in color online.
Image acquisition and manipulation
Images will be checked for manipulation when a paper is accepted. The Editorial Board may request that you supply the original data for comparison against the prepared figures. If you are unable to comply with such a request, the acceptance of the paper may be withdrawn.
ASN Neuro endorses the guidelines given in the Instructions for Authors of the Journal of Cell Biology, from where the following is adapted by kind permission of Rockefeller University Press:
The following information must be provided about the acquisition and processing of images:
1. Make and model of microscope
2. Type, magnification and numerical aperture of the objective lenses
4. Imaging medium
6. Camera make and model
7. Acquisition software
8. Any subsequent software used for image processing, with details about types of operations involved (e.g. type of deconvolution, 3D reconstructions, surface or volume rendering, gamma adjustments, etc.).
No specific feature within an image may be enhanced, obscured, moved, removed or introduced. The grouping of images from different parts of the same gel, or from different gels, fields or exposures must be made explicit by the arrangement of the figure (i.e. using dividing lines) and in the text of the figure legend. Adjustments of brightness, contrast or color balance are acceptable if they are applied to the whole image and as long as they do not obscure, eliminate or misrepresent any information present in the original, including backgrounds .The background of figures should be clearly distinct from the surrounding page. Non-linear adjustments (e.g. changes to gamma settings) must be disclosed in the figure legend.
You are encouraged to read the papers by M. Rossner and K. M. Yamada (2004) J. Cell Biol. 166,
11-15 and A. J. North (2006) J.Cell Biol. 172, 9-18.
In-line equations should be typed as text. Displayed equations (unless prepared by the 'Math Type Equation Editor') are re-keyed by our typesetter.
This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc) alongside the full-text of the article. These will be subjected to peer-review alongside the article. For more information please refer to our guidelines on submitting supplementary files, which can be found within our Manuscript Submission Guidelines page.
ASN Neuro offers you the opportunity to enhance your paper with movie files. These will be embedded in the final published version if your paper is accepted. To submit a paper with a movie file, simply upload the file when you submit your manuscript. Preferred formats are AVI, MPEG, Quicktime (MOV), MP4 and Flash.
Medline links and inter-journal linking:
ASN Neuro provides links to Medline citations, to related papers in Medline, to Medline citations for downloading to citation management software, and from references to the relevant abstracts in other online journals.
In the reference list, references should appear in alphabetical order by first author's last name. Include all authors' names (do not use "et al."), year, complete article title, journal, volume and inclusive page numbers. Abbreviate journal names according to PubMed; spell out the names of unlisted journals. Do not list unpublished material but cite parenthetically within the text as "unpublished data". Do not use others forms such as "manuscript in preparation," "manuscript submitted," "unpublished results" or "unpublished observation". Unpublished data may not be cited in the Materials and methods section. Unpublished data provided by a person(s) who is not an author of the article must be cited as a "personal communication". An authorization from this person(s) must be provided with the manuscript.Only published and "in press" (i.e., accepted for publication in a specific journal or book) references should appear in the reference list at the end of the paper. The latest information on "in press" references should be provided.
- One or two authors: (Smith, 2007); (Schenk and Matteoli, 2008)
- More than two authors: (Jones et al., 2006)
- If style requires, the format Jones et al. (2006) is also acceptable
- Multiple dates, same author(s): (Smith et al., 2005a, 2005b)
- In date order: (Zhou et al., 1999; Ari et al., 2004)
• Baptista MJ, O'Farrell C, Daya S, Ahmad R, Miller DW, Hardy J, Farrer MJ, Cookson MR (2003) Co-ordinate transcriptional regulation of dopamine synthesis genes by alpha-synuclein in human neuroblastoma cell lines. J Neurochem 85:957-968.
• Benton RL, Maddie MA, Minnillo DR, Hagg T, Whittemore SR (2008a) Griffonia simplicifolia isolectin B4 identifies a specific subpopulation of angiogenic blood vessels following contusive spinal cord injury in the adult mouse. J Comp Neurol 507:1031-1052.
• Benton RL, Maddie MA, Worth CA, Mahoney ET, Hagg T, Whittemore SR (2008b) Transcriptomic screening of microvascular endothelial cells implicates novel molecular regulators of vascular dysfunction after spinal cord injury. J Cereb Blood Flow Metab. 28:1771-1785.
Journal article in press:
• Paez PM, Fulton D, Colwell CS, Campagnoni AT (2008) Voltage-operated Ca2+ and Na+ channels in the oligodendrocyte linage. J Neurosci Res (in press).
• Beal MF, Howell N, Bodis-Wollner I (1997) Mitochondria and Free Radicals in Neurodegerative Diseases. New York: Wiley-Liss.
Chapter in a book:
• Parker WD, Davis RE (1997) Primary mitochondrial defects as a causative event in Alzheimer's disease. In: mitochondria and Free Radicals in Neurodegenerative Diseases (Beal MF, Howell N, Bodis-Wollner I, eds), pp.
319-324. New York: Wiley-Liss.
References are often the cause of many proof corrections, and inaccuracies hamper interjournal linking and Medline links in the journal. Please check the list carefully before submission.
WWW URLs are permitted in the text only, not in the reference list, and should be quoted only when a literature reference(s) will not suffice.
Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit SAGE Language Services on our Journal Author Gateway for further information.
The Title page should contain the following:
- Article title
- Name(s) of author(s) (with first or second given name spelled out in full)
- Author affiliation(s)
- Short running title (abbreviated form of title) of less than 45 characters including spaces
- Name and complete mailing address (including telephone and fax numbers and email address) of the person to whom correspondence should be sent
- Up to six key words (in alphabetical order), of which at least three do not appear in the title of the paper
- List of abbreviations used
- Any footnotes
Abstract (maximum 250 words; no subheadings)
Summary statement: this should highlight the key finding of your study. The statement should not exceed 40 words and should be written for a broad audience without the use of abbreviations and acronyms that are not widely known.
Materials and methods (or Experimental)
Funding (in the form of a sentence with the funding agency written out in full followed by the grant number in square brackets)
References (If you are using Endnote as a reference manager, the format for ASN Neuro is the same as the Journal of Neuroscience.)
Tables should be numbered with Arabic numerals (Table 1, Table 2, etc.) and cited consecutively in the text. Each table should have a title and an explanatory legend. Units must be clearly indicated for each of the entries in the table. Footnotes to tables should be identified by superscript lower-case roman letters and placed at the bottom of the table. Your tables should be prepared using the Microsoft Word table editor.
Figures should be cited consecutively in the text by Arabic numerals (Figure 1, Figure 2, etc.). Each figure should have a title and an explanatory legend. No artwork should be incorporated into the text files. Figures should be supplied as electronic files. Lettering on the figures should be of a size that allows for appropriate reduction of the figures.
ASN Neuro is pleased to be part of the Resource Identification Initiative, a project aimed at clearly identifying key biological resources used in the course of scientific research. This project helps address concerns of reproducibility by providing unique searchable identifiers, Research Resource Identifiers (RRIDs), for critical reagents and tools. RRIDs can be used to link readers to external resources, and they also enable search engines to return all papers in which a particular antibody, organism, or tool was used. We see these as important steps toward ensuring reproducible methods and providing critical data to help researchers identify suitable reagents and tools, and we are now asking authors to include RRIDs in their manuscripts.
How to Find an RRID
Fortunately, obtaining an RRID is fairly simple: visit https://scicrunch.org/resources and enter your search term(s) there.
- Search tip for antibodies: searching for the catalog number usually narrows the search to only a few relevant results.
- Cell Lines: searching for the catalog number of an established cell line is usually best, searching for common cell lines such as HeLa cells is expected to produce several pages of results.
- Search tip for organisms: you can include PubMed IDs (PMIDs) in your search or filter your search results by PMID, species, phenotype, and other criteria.
- Search for software tools: usually the name of the tool (MATLAB or ImageJ) or the institution where it is housed will bring back relevant results.
- For more search tips and help, contact firstname.lastname@example.org.
How to Include RRIDs in Your Paper
Once you have located an RRID, please insert "RRID:" plus the identifier in the appropriate location in the manuscript, with no space between the colon and the identifier. For example:
- Antibodies: "Sections were stained with a rabbit polyclonal antibody against ERK1 (Abgent Cat# AP7251E, RRID:AB_2140114)."
- Cell Lines: "Subjects include the following cell line: CLS Cat# 300384/p699_HeLa_S3, RRID:CVCL_0058.”
- Genetically modified organisms: "Subjects in this study were Fgf9Eks/Fgf9+ mice (RRID:MGI_3840442)..."
- Software tools: "...terminals were mapped with a computer-assisted mapping program (Neurolucida, v 10; MicroBrightField RRID:nif-0000-10294)."
How to Request an RRID
When you cannot find an RRID for a model organism or antibody that you used, you can help this initiative by submitting the reagent, as detailed below, so that it can be given proper identifiers for future use. The Resource Identification Portal includes mouse, zebrafish, worm, fruit fly, and rat model organisms as well as many commercial antibodies and some lab-sourced ones. When you cannot find an RRID for one of these five model organisms, please see the instructions at https://scicrunch.org/resources/about/guidelines#organism for submitting a new organism to the relevant model organism database. Antibodies can be added via the Antibody Registry (http://antibodyregistry.org/add); please note that login is required on that site.
Frequently Asked Questions
How is an RRID generated?
The Resource Identification Initiative builds on existing identifiers -- for instance, from model organism databases and from the Antibody Registry. Read more at https://scicrunch.org/resources/about/resource.
How long does it take to generate a new RRID?
Based on the F1000 paper on the pilot, about one week.
Where should the RRID be provided?
In the Experimental Procedures or Supplemental Experimental Procedures of your paper.
Validation criteria for key biological resources?
- Antibodies used: For each antibody used, did authors state which validation criteria was used to test whether the antibody was appropriate for their system? Was any supplemental validation data included or otherwise accessible?
- Cell lines used: Does the cell line have an ICLAC validation error? Information is available in the comment section of scicrunch.org/resources or cellosaurus database. Did authors validate cell line authenticity at the onset and close of the data gathering?
- Organisms used: Did authors provide information about the organism including the background strain, not just the allele?
ASN Neuro is hosted on SAGE Track, a web based online submission and peer review system powered by ScholarOne™ Manuscripts. Visit http://mc.manuscriptcentral.com/asnneuro to login and submit your article online.
IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created. For further guidance on submitting your manuscript online please visit ScholarOne Online Help.
Please supply a title, short title, an abstract and keywords to accompany your article. The title, keywords and abstract are key to ensuring readers find your article online through online search engines such as Google. Please refer to the information and guidance on how best to title your article, write your abstract and select your keywords by visiting the SAGE Journal Author Gateway for guidelines on How to Help Readers Find Your Article Online.
Provide full contact details for the corresponding author including email, mailing address and telephone numbers. Academic affiliations are required for all co-authors. These details should be presented separately to the main text of the article to facilitate anonymous peer review.
You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files
(including reporting guidelines where relevant).
As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a unique and persistent digital identifier that distinguishes researchers from every other researcher, even those who share the same name, and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities, ensuring that their work is recognized.
The collection of ORCID iDs from corresponding authors is now part of the submission process of this journal. If you already have an ORCID iD you will be asked to associate that to your submission during the online submission process. We also strongly encourage all co-authors to link their ORCID ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID iD will become part of your accepted publication’s metadata, making your work attributable to you and only you. Your ORCID iD is published with your article so that fellow researchers reading your work can link to your ORCID profile and from there link to your other publications.
Authors are responsible for obtaining permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.
You should submit your paper at http://mc.manuscriptcentral.com/asnneuro, where full instructions are available. Submission checklist:
- Covering letter
- Master electronic copy of typescript, as a one-line-spaced DOC:
- Complete text in appropriate style, pages numbered
- Full names and addresses of authors
- Full name, address, telephone and fax numbers and email address of corresponding author (all correspondence and proofs will be sent to this author)
- Movie files
- Supplementary material (e.g. large data sets)
- Related papers in press or under editorial consideration
- Evidence of approval of personal communications
- Evidence of submission of nucleic acid or protein sequences to an appropriate data bank.
You are required to suggest the names of two Senior Editors to handle your paper. You may also specify the names of those reviewers you wish to have excluded from the review process for a particular paper; in such cases your wishes will usually be respected, unless, of course, in the opinion of the journal such a request unreasonably excludes all the expertise available to it in that scientific area.
If your paper is accepted for publication after peer review, you will first be asked to complete the contributor’s publishing agreement. Once your manuscript files have been checked for SAGE Production, the corresponding author will be asked to pay the article processing charge (APC) via a payment link. Once the APC has been processed, your article will be prepared for publication and can appear online within an average of 30 days. Please note that no production work will occur on your paper until the APC has been received.
Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be sent by PDF to the corresponding author and should be returned promptly. Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate. Please note that if there are any changes to the author list at this stage all authors will be required to complete and sign a form authorizing the change.
One of the many benefits of publishing your research in an open access journal is the speed to publication. With no page count constraints, your article will be published online in a fully citable form with a DOI number as soon as it has completed the production process. At this time it will be completely free to view and download for all.
Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice. In addition, SAGE is partnered with Kudos, a free service that allows authors to explain, enrich, share, and measure the impact of their article. Find out how to maximize your article’s impact with Kudos.
Any correspondence, queries or additional requests for information on the Manuscript Submission process should be sent to the ASN Neuro editorial office as follows: